Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs HCTZ on Coronary Flow Reserve in Diabetic Hypertension
NCT00994253Phase 4Withdrawn
- Sponsor
- Corewell Health
- Start
- Aug 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in hypertension (HTN), sponsored by Corewell Health. Planned start Aug 2009; status: withdrawn.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00994253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994253.